Castelion Targets 2027 Production After Major Series B in Defense Tech

According to a recent LinkedIn post from Castelion, company leadership is signaling an intensive development and testing phase through 2026, with an eye toward initial production in 2027. The post references comments by co-founder and CFO Andrew Kreitz during a Nasdaq “Live from MarketSite” appearance, framed in the context of what is described as the largest Series B in defense tech history.

The LinkedIn post highlights three main operational priorities: completing development of Blackbeard, described as Castelion’s first hypersonic weapons system, building out “Project Ranger,” a 1,000-acre scaled production site, and accelerating work on a larger, longer-range system. These initiatives suggest a capital-intensive ramp-up that could move the company from R&D focus toward prospective revenue generation once production timelines are achieved.

For investors, the emphasis on hypersonic weapons and large-scale manufacturing infrastructure points to Castelion’s ambition to secure a meaningful role in next-generation defense capabilities. The described 2027 production target and reference to substantial Series B funding imply a multi-year runway where execution on development, testing, and facility build-out will likely be key determinants of future contract wins, valuation, and competitive positioning in the defense technology sector.